Executive Medical Director of Oncology for Premier Research, Emile Youssef, discusses crucial challenges that must be addressed in order to fulfill the promise of precision oncology.
... /Read more/
The time to stop hammering square pegs into round holes in terms of design strategy has come as sponsors embrace an adaptive supply chain approach.
... /Read more/
CDER's Rare Disease Cures Accelerator initiative looks to foster a coordinated research approach and methods that can expedite development of drugs to treat some of the 7,000 rare diseases.
... /Read more/
